names of glp 1 drugs for weight loss GLP-1 Medications: Everything You Need to Know What's the Difference Between Brand-Name

The emergence of sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists has reshaped DKD management

Notably, approximately 40% of patients with baseline liver enzyme elevations achieved normal ALT after treatment

Danne T, Garg S, Peters AL et al (2019) International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium-glucose cotransporter (SGLT) inhibitors

Supporting Data: A recent study shows that individuals who consumed specific probiotic strains, like Bifidobacterium longum and Lactobacillus gasseri , experienced an increase in GLP-1 levels

Understanding these mechanisms and safety considerations helps patients appreciate why certain effects occur, particularly during the initial treatment phase

As new data emerge, clinicians are encouraged to stay informed through trusted platforms such as Healthcare.pro, where expert perspectives on evolving therapies are regularly shared